Fingerprint
Dive into the research topics of '5-Year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically